Wrong Atropine strength cases reported

macular degeneration: closeup of woman's hazel eye
PDL has warned pharmacists to pay careful attention when dispensing scripts for Atropine eye drops The organisation has received a number of incident reports featuring prescriptions for Atropine 0.01% eye drops incorrectly processed by pharmacists as the Atropt 1% proprietary product. “These errors may be occurring due to a lack of awareness of the indication

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Focus on innovative therapies
Next ‘Something has to change in the way Queensland approaches this.’